Nipro newsletter April 2026
Carterra 23/09/25
LB Bohle – 10.06.2025
PCI – 7th June 2024
Temax_Krautz

Current Edition

DDL 2026
Merxin March 2026
Terumo 05/01
SAE Media – Pre-filled syringes West Coast 19/11/25
Nipro April 2026
Volume 14 issue 3

The Pharma Drug Discovery Industry Should Look Towards Manufacturing as the Blueprint for Automation

Within the manufacturing sector – whether it’s transported, FMCGs, electronics or building materials – a modern approach to automation is already in place. Holistic,...
Continue Reading →
Sponsored Articles

A More Connected Future for Pharma

In the lead-up to the inaugural launch of Connect In Pharma, co-founder Wilfried Phipps provides insight into what visitors can expect at this new annual event desig...
Continue Reading →
News

Aragen expects to ride wave of US biotech growth in 2022 – influx of discovery capital is surging demand for CDMO services

Company plans wide-ranging investments and expansions to keep pace with demand driven by macro-changes and diversifying client base Aragen Life Sciences (for...
Continue Reading →
News

Mirati’s adagrasib scores encouraging results in KRAS-mutated lung cancer

US biotech company Mirati Therapeutics announced positive Phase II results for its investigational treatment adagrasib as a treatment for KRAS-mutated lung cancer. ...
Continue Reading →
Volume 13 Issue 3

Biotech in China: Maximising the Global Opportunity

Pharmaceutical companies from China are showing an increasing interest in international market opportunities, focusing on new drug developments in the biological fie...
Continue Reading →
News

Sartorius Stedim Biotech and Penn State University Announce Partnership

Sartorius Stedim Biotech and Penn State University have entered into a collaborative partnership to advance multidisciplinary teaching and research in biotechnology....
Continue Reading →
News

Sphere Fluidics and Geneva Biotech receive Eurostars genome editing grant

Sphere Fluidics, a company providing single cell analysis systems underpinned by its patented picodroplet technology, and Geneva Biotech, an EMBL spin-out devel...
Continue Reading →
News

Immuno-oncology CRO secures Macrophage Pharma agreement

Aquila BioMedical Ltd., an innovative preclinical contract research organisation (CRO) now part of Concept Life Sciences group, has secured an extended agreement wit...
Continue Reading →
SMI London
Biopharma group march 2026
Silgan March 2026
Scott Pharma – 25.03.2025
Bespak – 21.05.2025
Aptar – 08/01/2026
Stoelzle – 15th May 2025
L.B. Bohle – 08.04.2025